Search results
Richard Michael Krause (January 4, 1925 – January 6, 2015) was an American physician, microbiologist, and immunologist. He was the director of the National Institute of Allergy and Infectious Diseases from 1975 to 1984.
Jan 14, 2015 · Richard M. Krause, a microbiologist and immunologist who steered the National Institute of Allergy and Infectious Diseases through the early, tumultuous years of the AIDS epidemic, died Jan....
by WYNNE PARRY. Richard M. Krause, a former Rockefeller University faculty member who later became director of the U.S. National Institute of Allergy and Infectious Disease and presciently warned against complacency toward infectious disease, has died at the age of 90.
People also ask
Who was Richard Krause?
Who was Dr Krause & what did he do?
Who is Dr Frederick Krause?
Who is Dr Steven Krause?
Aug 13, 2019 · Appointed the director of NIAID in 1975, Dr. Krause was among the first to perceive "the return of the microbes." He guided the Institute through a period of growth to cope with the re-emergence of microbial diseases as health threats and to stimulate research on the complexity of the immune system.
Feb 25, 2015 · Richard M. Krause, M.D. Jan. 4. 1925–Jan. 6. 2015. Richard Michael Krause, M.D. medical microbiologist, immunologist, and later science administrator, was born in Marietta, Ohio, USA, where his father was professor of chemistry at Marietta College, and where Krause received his BA in 1947. He went on to study medicine at Case Western Reserve ...
- Klaus Eichmann
- eichmann@immunbio.mpg.de
- 2015
Feb 2, 2016 · Richard M. Krause stands at the Nashville, Tennessee, gravesite of his hero Oswald T. Avery (1877–1955), the Rockefeller scientist who developed bacterial disease immunotherapy and studied the mysterious phenomenon of pneumococcal transformation. The transforming factor turned out to be DNA.
Feb 1, 2016 · Richard M. Krause stands at the Nashville, Tennessee, gravesite of his hero Oswald T. Avery (1877–1955), the Rockefeller scientist who developed bacterial disease immunotherapy and studied the mysterious phenomenon of pneumococcal transformation. The transforming factor turned out to be DNA.